BioTek Instruments has received DLReady™ certification for dual-luciferase assays on both the Synergy™ 2 and Synergy™ HT multi-detection microplate readers. Awarded by Promega Corporation, this certification validates an instrument to the highest performance levels and standards for the Dual-Luciferase® Reporter (DLR™) Assay System, which is one of the most common luminescence-based assays for measuring gene transcription and control in microplate format.

The DLR Assay System provides rapid quantitation of firefly and Renilla luciferase reporters in transfected cells or in cell-free transcription/translation reactions. The combination of two reporter assays in one system provides improved efficiency in less time with attomole sensitivities and no endogenous activity in the experimental host cells.

Synergy 2 and Synergy HT multi-detection microplate readers provide flexibility and performance through a variety of detection modes in addition to luminescence and injection options, including Fluorescence Intensity, Time Resolved Fluorescence and UV-Vis Absorbance. Synergy 2 also offers Fluorescence Polarization and increased detection sensitivity. Each multi-detection microplate reader is powered by BioTek’s Gen5™ data analysis software.

BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. The BioTek Instruments, Inc. instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.

DLR and DLReady logo are trademarks of Promega Corporation. Dual-Luciferase is a trademark of Promega Corporation and is registered with the U.S. Patent and Trademark Office.


For further information, contact:

Xavier Amouretti, Product Manager
BioTek Instruments, Inc.
(802) 655-4040
amourettix@biotek.com

Chere Griffin
Shaw & Todd Advertising and Marketing Communications
(908) 668-1106 x15
cgriffin@shawtodd.com